{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:58:55Z","timestamp":1790780335779,"version":"4.1.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Regulatory T cells (Tregs) play a critical role in maintaining self-tolerance and in containing allo-immune responses in the context of transplantation. Recent advances yielded the approval of the first pharmaceutical costimulation blockers (abatacept and belatacept), with more of them in the pipeline. These costimulation blockers inhibit effector cells with high clinical efficacy to control disease activity, but might inadvertently also affect Tregs. Treg homeostasis is controlled by a complex network of costimulatory and coinhibitory signals, including CD28, the main target of abatacept\/belatacept, and CTLA4, PD-1 and ICOS. This review shall give an overview on what effects the therapeutic manipulation of costimulation has on Treg function in transplantation.<\/jats:p>","DOI":"10.3389\/fimmu.2022.969633","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:09:30Z","timestamp":1662095370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Costimulation blockade and Tregs in solid organ transplantation"],"prefix":"10.3389","volume":"13","author":[{"given":"Moritz","family":"Muckenhuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wekerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00910-8","article-title":"Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4(+) T cell perturbations","volume":"22","author":"Zemmour","year":"2021","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf5264","article-title":"Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients","volume":"13","author":"Chen","year":"2021","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20120914","article-title":"Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells","volume":"209","author":"Weiss","year":"2012","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0351-z","article-title":"Regulatory T cell adaptation in the intestine and skin","volume":"20","author":"Whibley","year":"2019","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.053","article-title":"Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification","volume":"151","author":"Samstein","year":"2012","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature10772","article-title":"Extrathymically generated regulatory T cells control mucosal TH2 inflammation","volume":"482","author":"Josefowicz","year":"2012","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01001-4","article-title":"Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity","volume":"22","author":"Hu","year":"2021","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary sjogren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501740","article-title":"TGF-beta-Induced regulatory T cells directly suppress b cell responses through a noncytotoxic mechanism","volume":"196","author":"Xu","year":"2016","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill b lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0280-2","article-title":"Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells","volume":"20","author":"Akkaya","year":"2019","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw0902","article-title":"CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells","volume":"4","author":"Ovcinnikovs","year":"2019","journal-title":"Sci Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.8094901","article-title":"Identification of regulatory T cells in tolerated allografts","volume":"195","author":"Graca","year":"2002","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.8094901","article-title":"\"Infectious\" transplantation tolerance","volume":"259","author":"Qin","year":"1993","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T cells control antigen-specific expansion of tfh cell number and humoral immune responses via the coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048795","article-title":"Regulatory T cells and transplantation tolerance: Emerging from the darkness","volume":"51","author":"Waldmann","year":"2021","journal-title":"Eur J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13617","article-title":"Hepatic infiltrates in operational tolerant patients after liver transplantation show enrichment of regulatory T cells before proinflammatory genes are downregulated","volume":"16","author":"Taubert","year":"2016","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01621.x","article-title":"Multiparameter immune profiling of operational tolerance in liver transplantation","volume":"7","author":"Martinez-Llordella","year":"2007","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.3.1080","article-title":"CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-Dependent immunoregulation of alloresponses","volume":"168","author":"Kingsley","year":"2002","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03018.x","article-title":"Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning","volume":"10","author":"Pilat","year":"2010","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16724","article-title":"In vivo treg expansion under costimulation blockade targets early rejection and improves long-term outcome","volume":"21","author":"Schwarz","year":"2021","journal-title":"Am J Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.634260","article-title":"A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex001)","volume":"7","author":"Oberbauer","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003474","article-title":"One for all and all for one: The triumph of the one study","volume":"105","author":"Alexander","year":"2021","journal-title":"Transplantation"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"Sanchez-Fueyo","year":"2020","journal-title":"Am J Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh207","article-title":"CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production","volume":"17","author":"Barthlott","year":"2005","journal-title":"Int Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ni1264","article-title":"Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling","volume":"6","author":"D'Cruz","year":"2005","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.022","article-title":"Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals","volume":"38","author":"Tai","year":"2013","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122759","article-title":"IL-2 coordinates IL-2-producing and regulatory T cell interplay","volume":"210","author":"Amado","year":"2013","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and b lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182232","article-title":"PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance","volume":"218","author":"Tan","year":"2020","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142909","article-title":"Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms","volume":"6","author":"Borges","year":"2021","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14342","article-title":"Regulatory T cells promote natural killer cell education in mixed chimeras","volume":"17","author":"Mahr","year":"2017","journal-title":"Am J Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-741629","article-title":"PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy","volume":"129","author":"Asano","year":"2017","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146245","article-title":"IL-2 \/ \u03b1-IL-2 complex treatment cannot be substituted for the adoptive transfer of regulatory T cells to promote bone marrow engraftment","volume":"11","author":"Mahr","year":"2016","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139991","article-title":"Selective expansion of regulatory T cells using an orthogonal IL-2\/IL-2 receptor system facilitates transplantation tolerance","volume":"131","author":"Hirai","year":"2021","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218159","article-title":"Delicate role of PD-L1\/PD-1 axis in blood vessel inflammatory diseases: Current insight and future significance","volume":"21","author":"Veluswamy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"107331","DOI":"10.1016\/j.carpath.2021.107331","article-title":"PD-1 and PD-L1 expression in cardiac transplantation","volume":"54","author":"Bishawi","year":"2021","journal-title":"Cardiovasc Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007982","article-title":"Endothelial stromal PD-L1 (Programmed death ligand 1) modulates CD8(+) T-cell infiltration after heart transplantation","volume":"14","author":"Bracamonte-Baran","year":"2021","journal-title":"Circ Heart Failure"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.741025","article-title":"Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy","volume":"117","author":"Yang","year":"2008","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-022-29930-0","article-title":"PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration","volume":"13","author":"Piao","year":"2022","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.05.016","article-title":"Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses","volume":"27","author":"Butte","year":"2007","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0316","article-title":"PD-L1 binds to B7-1 only in cis on the same cell surface","volume":"6","author":"Chaudhri","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/35069118","article-title":"Crystal structure of the B7-1\/CTLA-4 complex that inhibits human immune responses","volume":"410","author":"Stamper","year":"2001","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","article-title":"PD-L1:CD80 cis-heterodimer triggers the Co-stimulatory receptor CD28 while repressing the inhibitory PD-1 and CTLA-4 pathways","volume":"51","author":"Zhao","year":"2019","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.2.302","article-title":"Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo","volume":"165","author":"Jenkins","year":"1987","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.600000","article-title":"CD86 is a selective CD28 ligand supporting FoxP3+ regulatory T cell homeostasis in the presence of high levels of CTLA-4","volume":"11","author":"Halliday","year":"2020","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1485489","article-title":"Belatacept\/CTLA4Ig: an update and critical appraisal of preclinical and clinical results","volume":"14","author":"Schwarz","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13872","article-title":"The immunosuppressive effect of CTLA4 immunoglobulin is dependent on regulatory T cells at low but not high doses","volume":"16","author":"Schwarz","year":"2016","journal-title":"Am J Transplant"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-ig on a treg-dependent transplant model","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9527-5","article-title":"CTLA-4-Ig therapy diminishes the frequency but enhances the function of treg cells in patients with rheumatoid arthritis","volume":"31","author":"Alvarez-Quiroga","year":"2011","journal-title":"J Clin Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65013","article-title":"An obligate cell-intrinsic function for CD28 in tregs","volume":"123","author":"Zhang","year":"2013","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.108","article-title":"Promiscuous Foxp3-cre activity reveals a differential requirement for CD28 in Foxp3(+) and Foxp3(-) T cells","volume":"93","author":"Franckaert","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000421","article-title":"CTLA4-ig preserves thymus-derived T regulatory cells","volume":"98","author":"Ahmadi","year":"2014","journal-title":"Transplantation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2484825","DOI":"10.1155\/2018\/2484825","article-title":"CTLA4Ig improves murine iTreg induction via TGFbeta and suppressor function in vitro","volume":"2018","author":"Pilat","year":"2018","journal-title":"J Immunol Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"9636897211046556","DOI":"10.1177\/09636897211046556","article-title":"Benefit of belatacept in cord blood-derived regulatory T cell-mediated suppression of alloimmune response","volume":"30","author":"He","year":"2021","journal-title":"Cell Transplant"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01223.x","article-title":"Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation","volume":"24","author":"Bestard","year":"2011","journal-title":"Transpl Int"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02377.x","article-title":"The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation","volume":"8","author":"Bluestone","year":"2008","journal-title":"Am J Transplant"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601670","article-title":"TCR signaling and CD28\/CTLA-4 signaling cooperatively modulate T regulatory cell homeostasis","volume":"198","author":"Holt","year":"2017","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the b cell activation antigen B7","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89381","article-title":"Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses","volume":"2","author":"Zaitsu","year":"2017","journal-title":"JCI Insight"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0135-0_21","article-title":"T Cell apoptosis by kynurenines","volume":"527","author":"Fallarino","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2007.08.019","article-title":"Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction","volume":"126","author":"Davis","year":"2008","journal-title":"Clin Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000255594.23445.29","article-title":"CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of indoleamine-2,3-dioxygenase","volume":"83","author":"Pree","year":"2007","journal-title":"Transplantation"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13093","article-title":"No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients","volume":"192","author":"Bigenzahn","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16538","article-title":"Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial","volume":"21","author":"Badell","year":"2021","journal-title":"Am J Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1038\/s41467-019-10812-x","article-title":"Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis","volume":"10","author":"Serwas","year":"2019","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861471","article-title":"The inhibition of CD40\/CD154 costimulatory signaling in the prevention of renal transplant rejection in nonhuman primates: A systematic review and meta analysis","volume":"13","author":"Perrin","year":"2022","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15835","article-title":"CD11b is a novel alternate receptor for CD154 during alloimmunity","volume":"20","author":"Liu","year":"2020","journal-title":"Am J Transplant"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903888","article-title":"Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice","volume":"185","author":"Robles-Carrillo","year":"2010","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14197","article-title":"Fc-silent anti-CD154 domain antibody effectively prevents nonhuman primate renal allograft rejection","volume":"17","author":"Kim","year":"2017","journal-title":"Am J Transplant"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1105500108","article-title":"Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40\/CD154 blockade","volume":"108","author":"Ferrer","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010352","article-title":"Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation","volume":"5","author":"Muller","year":"2010","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03623.x","article-title":"CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant","volume":"11","author":"Dodd-o","year":"2011","journal-title":"Am J Transplant"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-ig and anti-CD40 ligand prevent renal allograft rejection in primates","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.969633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:09:34Z","timestamp":1662095374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.969633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":103,"alternative-id":["10.3389\/fimmu.2022.969633"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.969633","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"969633"}}